UnitedHealthcare: Gardasil Covered for Males
UnitedHealthcare has expanded its coverage of Gardasil®. Effective Feb. 1, 2012, the insurer will cover the HPV4 vaccine for both females and males aged 9-26 years, according to UnitedHealthcare’s March 2012 Network Bulletin.
This coverage is based on new recommendations made by the Advisory Committee on Immunization Practices (ACIP) in October 2011 for Human Papillomavirus Quadrivalent (Types 6, 11, 18, and 18) Vaccine, Recombinant (Gardasil).
Human papilloma virus (HPV) can cause cervical, vaginal, and vulvar cancers in females, and genital warts in both males and females, according to Merck & Co., Inc.—the manufacturer of Gardasil.
Merck says the commonly used codes below may apply to private payer reimbursement for vaccination with Gardasil:
|90649||Human Papilloma virus (HPV) vaccine, types 6, 11, 16, 18 (quadrivalent), 3 dose schedule, for intramuscular use|
|90471||Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)|
|V04.89||Need for prophylactic vaccination and inoculation against other viral diseases|
|V05.8||Need for prophylactic vaccination and inoculation against other specified disease|
- Message From Your Region 6 Representatives | Pam Tienter and Jean Pryor - January 16, 2020
- Message From Your Region 3 Representatives | Astara Crews and Dianne Estes - January 16, 2020
- Message From Your Region 7 Representatives | Robert Kiesecker and Pam Brooks - January 16, 2020